An observational study on bacterial infections in hospitalized coronavirus patients in a tertiary care center

Authors

Keywords:

sepsis, bacterial infection, etiology, ICU

Abstract

Introduction: The latest global pandemic is caused by SARS-CoV-2 coronavirus. 6% of patients are admitted to the hospital, with 20% of those admitted to the intensive care unit (ICU) due to acute respiratory distress syndrome (ARDS).

Aim: to characterise the bacterial infections in patients with coronavirus at an ICU of North Indian Hospital.

Method: After receiving ethical approval from the institutional review board, a retrospective study was done on coronavirus subjects admitted to GMC Srinagar's ICUs between January and June 2021. Data on demographics, comorbidities, and microbiology were obtained retrospectively.

Results: Overall, “394 COVID-19 patients were admitted to ICU. Median age was 58 years (IQR 51–69) and sex ratio (M/F) was 3. At admission the median SAPS II was 33 (IQR 24–49). Among patients, 232 had at least one co-morbidity and 162 were overweight (body mass index (BMI) = 27.8 kg/m2). In all, 358 patients received antibiotics (244/358 introduced before ICU and 114/358 during ICU stay)”.

Conclusion: The current study is the first of its kind in our hospital setting to describe the bacterial persistence in the lungs despite adequate therapy, as well as frequent bloodstream infections possibly associated with bacterial translocations originating from the digestive or oropharyngeal microbiota, in COVID-19 ICU patients.

Downloads

Download data is not yet available.

References

1. Machhi J, Herskovitz J, Senan AM, Dutta D, Nath B, D Oleynikov M, et al. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. J Neuroimmune Pharmacol [Internet]. 2020 [cited 12 Oct 2021];15(3):359-386. Available in: https://pubmed.ncbi.nlm.nih.gov/32696264/

2. Tizaoui K, Zidi I, Lee KH, Abou Ghayda R, Hwi Hong S, Li H, et al. Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19). Int J Biol Sci [Internet]. 2020 [cited 12 Oct 2021];16(15):2906-2923. Available in: https://www.ijbs.com/v16p2906.htm

3. Langford BJ, So M, Raybardhan S, Leung V, Westwood D, R MacFadden D, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clinical Microbiology and Infection [Internet]. 2020 [cited 12 Oct 2021]; 26(12):1622-1629. Available in: https://pubmed.ncbi.nlm.nih.gov/32711058/

4. Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect [Internet]. 2020 [cited 12 Oct 2021];81(2):266-275. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255350/

5. Rawson TM, Moore LSP, Castro-Sanchez E, Charani E, Davies F, Satta G, et al. COVID-19 and the potential long-term impact on antimicrobial resistance. J Antimicrob Chemother [Internet]. 2020 [cited 12 Oct 2021]; 75(7):1681-1684. Available in: https://pubmed.ncbi.nlm.nih.gov/32433765/

6. Huttner BD, Catho G, Pano-Pardo JR, Pulcini C, Schouten J. COVID-19: don't neglect antimicrobial stewardship principles! Clin Microbiol Infect [Internet]. 2020 [cited 12 Oct 2021];26(7):808-810. Available in: https://pubmed.ncbi.nlm.nih.gov/32360446/

7. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, B Palmer L, et al. Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. [Internet] 2016 [cited 12 Oct 2021];63(5):e61-e111. Available in: https://pubmed.ncbi.nlm.nih.gov/27418577/

8. Niederman MS. Hospital-acquired pneumonia, health care-associated pneumonia, ventilator-associated pneumonia, and ventilator-associated tracheobronchitis: definitions and challenges in trial design. Clin Infect Dis. [Internet] 2010 [cited 12 Oct 2021];51 Suppl 1:S12-7. Available in: https://pubmed.ncbi.nlm.nih.gov/20597660/

9. Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med [Internet]. 2020 [cited 12 Oct 2021]; 382(24):2372–4. Available in: https://pubmed.ncbi.nlm.nih.gov/32302078/

10. Sepulveda J, Westblade LF, Whittier S, Satlin MJ, Greendyke WG, Aaron JG, et al. Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City. J Clin Microbiol. [Internet] 2020 [cited 13 Oct 2021] 23;58(8):e00875-20. Available in: https://pubmed.ncbi.nlm.nih.gov/32404482/

11. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. [Internet] 2020 [cited ];382(21):2012-2022. Available in: https://pubmed.ncbi.nlm.nih.gov/32227758/

12. Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. [Internet] 2021 [cited 14 Oct 2021];27(1):83-88. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836762/

13. Dudoignon E, Caméléna F, Deniau B, Habay A, Coutrot M, Ressaire Q, et al. Bacterial Pneumonia in COVID-19 Critically Ill Patients: A Case Series. Clin Infect Dis. [Internet] 2021 [cited ];72(5):905-906. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337703/

14. Di Gennaro F, Marotta C, Amicone M, Bavaro DF, Bernaudo F, Frisicale EM, et al. Italian young doctors' knowledge, attitudes and practices on antibiotic use and resistance: A national cross-sectional survey. J Glob Antimicrob Resist. [Internet] 2020 [cited 14 Oct 2021];23:167-173. Available in: https://pubmed.ncbi.nlm.nih.gov/32971291/

15. Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med. [Internet] 2020 [cited

16 Oct 2021];383(2):120-128. Available in: https://pubmed.ncbi.nlm.nih.gov/32437596/

16. Albin OR, Henig O, Patel TS, Valley TS, Pogue JM, Petty LA, et al. Clinical Implications of Microbiologic Treatment Failure in the Setting of Clinical Cure of Bacterial Pneumonia. Clin Infect Dis. [Internet] 2020 [cited 16 Oct 2021];71(12):3033-3041. Available in: https://pubmed.ncbi.nlm.nih.gov/31832641/

Downloads

Published

2022-04-06

How to Cite

1.
Iqbal I, Farhana A, Farooq SS. An observational study on bacterial infections in hospitalized coronavirus patients in a tertiary care center. Revdosdic [Internet]. 2022 Apr. 6 [cited 2025 Mar. 14];5(1):e292. Available from: https://revdosdic.sld.cu/index.php/revdosdic/article/view/292

Issue

Vol. 5 No. 1 (2022): JANUARY - MARCH

Section

Original Articles

License

Authors who have publications with this journal agree to the following terms: authors retain their copyright and grant the journal the right of first publication of their work, which is simultaneously subject to the Creative Commons Attribution-NonCommercial 4.0 International License that allows third parties to share the work as long as the author and first publication in this journal are indicated, for non-commercial use. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional telematic archive or publishing it in a monographic volume) as long as the initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work via the Internet (e.g., in institutional telematic archives, in their web page or in Pre-print servers) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The Open Access Effect).